| Description | Bentamapimod(AS602801)isanovel,orallyactiveJNKinhibitorwithIC50valuesof80nM,90nMand230nMforJNK1,JNK2andJNK3respectively. | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Targets |
| |||||||||||
| Invitro | Invitro,AS602801exhibitscytotoxicityagainstbothserum-culturednon-stemcancercellsandcancerstemcellsderivedfromhumanpancreaticcancer,non-smallcelllungcancer,ovariancancerandglioblastomaatconcentrationsthatdoesnotdecreasetheviABIlityofnormalhumanfibroblasts.AS602801alsoinhibitstheself-renewalandtumor-initiatingcapacityofcancerstemcellssurvivingAS602801treatment[2]. | |||||||||||
| Assay |
|